Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China flag China · Delayed Price · Currency is CNY
9.06
-0.02 (-0.22%)
Aug 3, 2026, 3:04 PM CST

Aier Eye Hospital Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
3,3713,2403,5563,3592,5242,323
Depreciation & Amortization
1,7481,7481,5941,3471,166951.72
Other Amortization
487.56487.56352.71318.3224.17173.07
Loss (Gain) From Sale of Assets
-9.82-9.82-4.27-0.711.25-0.05
Asset Writedown & Restructuring Costs
164.18164.18194.52389.72100.34220.94
Loss (Gain) From Sale of Investments
-166.53-166.53-547.6232.9315.49343.61
Provision & Write-off of Bad Debts
125.31125.31116.31107.4477.2797.89
Other Operating Activities
201.43444.83441.84443.31203.62234.42
Change in Accounts Receivable
115.22115.22-40.75-264.53-68.21-109.44
Change in Inventory
3.543.54-85.87-168.65-159.47-37.58
Change in Accounts Payable
-239.9-239.9-877.11136.05-48.99-206.86
Change in Other Net Operating Assets
464682.07145.39228.44126.8
Operating Cash Flow
5,8605,9734,8825,8724,4914,084
Operating Cash Flow Growth
8.29%22.35%-16.86%30.76%9.96%22.15%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-1,969-2,093-1,830-1,460-1,388-1,494
Sale of Property, Plant & Equipment
7.825.835.565.557.816.37
Cash Acquisitions
-910.28-621.5-1,966-1,586-1,126-945.53
Divestitures
----0.18-
Investment in Securities
-475.69-443.15729.12-305.88-795.67-250.32
Other Investing Activities
58.1455.54213.2541.7542.4169.16
Investing Cash Flow
-3,289-3,096-2,848-3,304-3,260-2,514

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,6361,506863.31438.21720.32
Long-Term Debt Repaid
--2,644-1,870-1,422-2,350-1,170
Net Debt Issued (Repaid)
-778.43-1,008-364.64-559.03-1,912-449.79
Issuance of Common Stock
----3,8521,296
Repurchase of Common Stock
-38.47-38.47-46.36-576.16-5.1-3.18
Common Dividends Paid
-2,262-1,525-1,419-746.9-672.56-662.5
Other Financing Activities
-525.33-380.38-903.55-627.63-872.55-420.08
Financing Cash Flow
-3,604-2,952-2,734-2,510390.43-239.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-31.26-5.97-23.4434.8421.7110.39
Net Cash Flow
-1,065-81.1-723.8192.571,6431,340

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
3,8913,8803,0524,4123,1022,590
Free Cash Flow Growth
9.10%27.15%-30.84%42.22%19.79%5.72%
Free Cash Flow Margin
17.12%17.36%14.54%21.66%19.26%17.27%
Free Cash Flow Per Share
0.420.420.330.480.340.29
Levered Free Cash Flow
3,1724,1292,5803,1072,6113,045
Unlevered Free Cash Flow
3,3364,2982,7403,2292,7223,148

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
1,2761,1361,1521,1671,0521,061
Change in Working Capital
-60.75-60.75-822.07-125.13-121.92-260.83